FM
RDHL

Family Management’s Redhill Biopharma RDHL Stock Holding History

Family Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38
Closed -$408K – 68
2017
Q3 		$408K Buy
38
+12
+46% +$107K 0.28% 45
2017
Q2 		$222K Buy
26
+9
+53% +$86.5K 0.15% 52
2017
Q1 		$163K Buy
+17
New +$170K 0.11% 58
2016
Q4 		– Sell
-17
Closed -$229K – 77
2016
Q3 		$229K Hold
17
– – 0.13% 68
2016
Q2 		$179K Hold
17
– – 0.1% 74
2016
Q1 		$202K Buy
17
+2
+13% +$20.9K 0.13% 64
2015
Q4 		$187K Sell
15
-7
-32% -$87.1K 0.1% 71
2015
Q3 		$284K Buy
+22
New +$326K 0.13% 76

Other funds holding RDHL

6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Family Management's RDHL Position: Q4 2017 in Review

Family Management sold out of Redhill Biopharma (RDHL) in Q4 2017, closing a stake of 38 shares — an estimated $408K sold.

Family Management first reported a position in RDHL in Q3 2015 and held it in 8 quarters. The position peaked at $408K in Q3 2017. 31 funds tracked by Wall St. Rank hold RDHL as of Q4 2017.

  • Family Management reported no remaining Redhill Biopharma position as of Q4 2017 after selling out during the quarter.
  • Family Management sold 38 Redhill Biopharma shares in Q4 2017, an estimated $408K.
  • Family Management first reported a position in Redhill Biopharma in Q3 2015 and held it in 8 quarters.
  • Family Management's Redhill Biopharma position peaked at $408K in Q3 2017.
  • 31 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2017.

Based on Family Management's 13F filing for Q4 2017, filed 15 Feb 2018.